Literature DB >> 23240671

A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours.

Joseph T Rabban1, Charles J Zaloudek.   

Abstract

Immunohistochemistry can be useful in the diagnosis of ovarian germ cell tumours and sex cord-stromal tumours. A wide variety of markers are available, including many that are novel. The aim of this review is to provide a practical approach to the selection and interpretation of these markers, emphasizing an understanding of their sensitivity and specificity in the particular differential diagnosis in question. The main markers discussed include those for malignant germ cell differentiation (SALL4 and placental alkaline phosphatase), dysgerminoma (OCT4, CD117, and D2-40), yolk sac tumour (α-fetoprotein and glypican-3), embryonal carcinoma (OCT4, CD30, and SOX2), sex cord-stromal differentiation (calretinin, inhibin, SF-1, FOXL2) and steroid cell tumours (melan-A). In addition, the limited role of immunohistochemistry in determining the primary site of origin of an ovarian carcinoid tumour is discussed.
© 2012 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23240671     DOI: 10.1111/his.12052

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  15 in total

1.  Endocrine pathology of the ovary : in tribute to Robert E Scully, MD.

Authors:  Esther Oliva; Robert H Young
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

2.  Steroid Cell Tumour of Ovary - A Rare Case Report.

Authors:  Ranjeev Bhagat; Vijay Kumar Bodal; Nishit Gupta; Pooja Garg
Journal:  J Clin Diagn Res       Date:  2016-09-01

3.  Pathologic Classification of Ovarian Cancer.

Authors:  Stephanie M McGregor
Journal:  Methods Mol Biol       Date:  2022

4.  Geminin Is Essential for Pluripotent Cell Viability During Teratoma Formation, but Not for Differentiated Cell Viability During Teratoma Expansion.

Authors:  Diane C Adler-Wailes; Joshua A Kramer; Melvin L DePamphilis
Journal:  Stem Cells Dev       Date:  2016-11-07       Impact factor: 3.272

5.  Renal cell carcinoma metastatic to the ovary or fallopian tube: a clinicopathological study of 9 cases.

Authors:  Li Liang; He Huang; Vipulkumar Dadhania; Jing Zhang; Miao Zhang; Jinsong Liu
Journal:  Hum Pathol       Date:  2016-01-07       Impact factor: 3.466

6.  Expression pattern of clinically relevant markers in paediatric germ cell- and sex-cord stromal tumours is similar to adult testicular tumours.

Authors:  Christiane Hammershaimb Mosbech; Terje Svingen; John Erik Nielsen; Birgitte Groenkaer Toft; Catherine Rechnitzer; Bodil Laub Petersen; Ewa Rajpert-De Meyts; Christina Engel Hoei-Hansen
Journal:  Virchows Arch       Date:  2014-07-30       Impact factor: 4.064

7.  MENOPAUSAL ANDROGEN EXCESS - ASSOCIATED CARDIO-METABOLIC RISK: CLUES FOR OVARIAN LEYDIG CELL TUMOUR (CASE REPORT AND MINI-REVIEW OF LITERATURE).

Authors:  A A Gheorghisan-Galateanu; D Terzea; A Valea; M Carsote
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Jul-Sep       Impact factor: 0.877

8.  Ovarian mucinous epithelial neoplasm showing immunohistochemical pattern of lower gastrointestinal origin with stromal minor sex-cord elements: A case report.

Authors:  Taeko Ueda; Hitomi Nakagawa; Toru Hachisuga
Journal:  Gynecol Oncol Rep       Date:  2014-12-06

Review 9.  Uncommon Metastasis of Ovarian Dysgerminoma: A Case Report and Review of the Literature.

Authors:  Mihaela Camelia Tîrnovanu; Irina Daniela Florea; Adina Tănase; Bogdan Florin Toma; Elena Cojocaru; Carmen Ungureanu; Ludmila Lozneanu
Journal:  Medicina (Kaunas)       Date:  2021-05-27       Impact factor: 2.430

10.  Comparison of immunohistochemical profiles of ovarian germ cells in dysgerminomas of a captive maned wolf and domestic dogs.

Authors:  Rafael B Rosa; Matheus V Bianchi; Paula R Ribeiro; Fernando F Argenta; Andréia Vielmo; Felipe A B de Sousa; Manoela M Piva; Camila B Pohl; Yasmin Daoualibi; Fernanda G Cony; Carolina B Brunner; Raquel Von Hohendorff; Luciana Sonne
Journal:  J Vet Diagn Invest       Date:  2021-05-28       Impact factor: 1.569

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.